Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
268.50
-13.45 (-4.77%)
Mar 9, 2026, 1:58 PM EDT - Market open
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $7.34 billion as of March 9, 2026. Its market cap has decreased by -7.97% in one year.
Market Cap
7.34B
Enterprise Value
7.19B
1-Year Change
-7.97%
Ranking
Category
Stock Price
$268.50
Market Cap Chart
Since March 10, 2021, Bio-Rad Laboratories's market cap has decreased from $16.68B to $7.34B, a decrease of -55.96%. That is a compound annual growth rate of -15.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.28B | -10.76% |
| Dec 31, 2025 | 8.16B | -11.13% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 35.61% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Insulet | 16.68B |
| Smith & Nephew | 14.76B |
| Penumbra | 13.29B |
| Globus Medical | 11.78B |
| Masimo | 9.16B |
| Bio-Rad Laboratories | 7.29B |
| Glaukos | 6.27B |
| Bruker | 5.58B |